Article

Allergan launches preservative-free drops

Refresh Optive Advanced Preservative-Free Lubricant Eye Drops (Allergan) work on all three layers of the tear film to relieve dry eye symptoms.

 

Irvine, CA-Allergan Inc. has launched Refresh Optive Advanced Preservative-Free Lubricant Eye Drops, which feature the same formula as Refresh Optive Advanced, but without the use of a preservative.

The preservative-free formula works on all three layers of the tear film to relieve dry eye symptoms, to stabilize the lipid layer to help reduce tear evaporation, hydrate the aqueous layer, and provide an advanced lubricating and protective shield to the mucin layer, while further protecting epithelial cells from hypertonic stress.

“[The preservative-free drops are] a lipid-enhanced tear that offers the comfort of an aqueous tear, but works layer by layer to stabilize the tear film, delivering just enough lipid to relieve symptoms without causing a lot of blur,” said Joseph Vehige, OD, Allergan senior director, consumer eye care research and development. “By stabilizing the lipid layer, tear evaporation is significantly reduced.”

 

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.